# S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence

> **NCT00722124** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 150 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** S-Adenosyl-L-Methionine
- **DRUG:** S-Adenosyl-L-Methionine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00722124
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2011-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722124, "S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00722124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*